Measles virus (MV) is a member of the morbillivirus subgroup of the Paramyxoviridae family. It contains a 15.9-kb negative-stranded RNA genome packaged within a characteristic helical nucleocapsid containing approximately 2,500 copies of the nucleocapsid (NP) protein, 300 copies of the phosphoprotein (P), and 40 copies of the large or L protein (28) . The nucleocapsid core associates with the matrix (M) protein and the viral envelope which is derived from the cellular plasma membrane and contains the virally encoded hemagglutinin (HA) and fusion (F) proteins. Gene cistrons encoding P proteins of the morbilliviruses and paramyxoviruses are so far unique among nonsegmented negative-stranded RNA viruses in their ability to encode a variety of distinct proteins from overlapping open reading frames (ORFs) by a number of mechanisms.
Translation initiation at the 5Ј-proximal AUG codon of the MV P protein mRNA generates the 507-amino-acid P protein, the largest protein product of the MV P cistron. Although the P protein is an essential component of active transcription complexes, it is believed that the enzymatic sites for transcription, capping, and polyadenylation are all contained within the L protein (18) . At the amino acid sequence level, P proteins encoded by paramyxoviruses and rhabdoviruses are more divergent than are any other of the virus-specific proteins. Despite this divergence, they retain a number of characteristics in common (reviewed in reference 33). Their structure consists, in general, of an extremely variable and highly phosphorylated acidic amino-terminal domain which has been shown to interact with the L protein (12, 22) . By analogy with the rhabdovirus P protein (sometimes designated as the NS protein), the degree of phosphorylation within this domain is likely to influence transcriptional activity (11, 25) . The somewhat more highly conserved carboxy-terminal domain has been shown to interact with the NP protein (9a, 19, 21, 41) . It may well be this absence of severe sequence constraint within these functional domains of P proteins that has allowed these viruses to evolve mechanisms which allow expression of overlapping ORFs from P gene cistrons.
Many members of the Paramyxoviridae family, including Sendai virus (15) , all four human parainfluenza virus types (PIV1, -2, -3, and 4 (14, 26, 31, 35, 45) , bovine PIV3 (42), canine distemper virus (40) , rinderpest virus (4), phocid distemper virus (6) , mumps virus (36) , and MV (5), encode one or more proteins analogous to the MV C protein. These nonstructural proteins are expressed from overlapping ORFs whose translation is initiated by ribosomes initiating not at the first but at the second 5Ј-proximal AUG initiation codon which is downstream of that used to initiate the translation of the P protein. No function has yet been determined for the 21-kDa MV C protein. An even more elaborate pattern of protein expression via alternative translation initiation has been demonstrated with alternative start codons (GUG and ACG, respectively) used to initiate translation of the CЈ proteins of human PIV1 and Sendai virus (7, 13) . Sendai virus also expresses two other proteins, Y 1 and Y 2 , using even more distal start codons. Collectively, these polypeptide products are all classified as C-type proteins, since they form a 3Ј-coterminous nested set with heterogeneity at their amino termini.
In addition to heterogeneity of ribosomal initiations sites, a separate mechanism, which has hitherto been termed RNA editing, allows the expression of additional proteins from the P cistrons of virtually all members of the Paramyxoviridae family so far studied. Exceptions to this include all members of the Pneumovirus genus, which should perhaps constitute an entirely separate family of viruses, and human PIV1 (reviewed in reference 39). This so-called RNA editing occurs cotranscriptionally and generates a population of additional mRNAs which differ from faithful transcripts of genome RNA by means of the addition of one or more G residues within stretches of G residues located approximately halfway through the main P cistron ORF (10, 47) . These events are believed to occur when the viral transcriptase complex ''stutters'' while transcribing a stretch of genomic C residues that is immediately distal to a sequence element that superficially resembles the intergenic termination/polyadenylation signal (48) . In vitro experiments have demonstrated that such editing can occur in the absence of cellular cofactors (20, 48) . The addition of G residues in numbers that are other than multiples of 3 alters the reading frame and generates mRNAs that encode proteins with identical amino termini but altered carboxy termini relative to the P protein. During MV transcription, the insertion of an additional G residue at nucleotide 753 of the P mRNA provides access to the Ϫ1 reading frame relative to that for P and results in the translation of a 68-amino-acid carboxy terminus that is unique to the resulting protein, which has been termed V (10) . The predicted protein sequence of this unique V-specific region is the most highly conserved sequence element among P cistron-related gene products (47) . All paramyxovirus V genes have conserved a cysteine-rich domain within which the number and spacing of cysteine residues resembles that of a number of zinc finger-type transcription factors. Although we have previously demonstrated that the MV V protein is capable of specifically binding zinc (30) , the importance of this activity to the function of the V protein remains unclear. The available evidence suggests that V may play a part in down-regulation of viral transcription (12, 16) . In some paramyxoviruses, editing also generates additional proteins, such as the W protein of Sendai virus (translated from the ϩ1 frame relative to P), the I protein of mumps virus (46) , and the D proteins of human and bovine PIV3 (37) .
In this report, we describe an additional mechanism allowing for differential protein expression from the MV P cistron. Ribosomal frameshifting allows access to the V ORF at a location distal to the site of editing in P protein-specific mRNAs. The resulting translational product, which we have designated R, has an amino acid sequence distinct from that of either the P or V protein yet terminates its translation at the same stop codon as does the V protein.
MATERIALS AND METHODS
Plasmid constructs. Synthesis of oligonucleotide primers was commissioned from the Regional DNA Synthesis Laboratory, University of Calgary, Calgary, Alberta, Canada. Restriction digestion and other manipulations were performed as described previously (3) . Enzymes were purchased from Pharmacia or Bethesda Research Laboratories (BRL). Plasmid pGEX-V was constructed by the PCR amplification and cloning of the MV V ORF into pGEX-2T as a BamHIto-EcoRI fragment, using the primers 5Ј-dGGATCCGCAGAAGAGCAGGCA CGC and 5Ј-dGAATTCTTATTCTGGGATCTCGGG. Plasmid pGEX-P was generated by the digestion of pGEX-V at a HindIII site located immediately 5Ј to the editing site and at an EcoRI site that is beyond the 3Ј end of the gene. This fragment was replaced with sequences corresponding to the unedited P mRNA derived from pAM18MV-P (50).
Amino-terminal deletions designed to map the location of the putative frameshift site were generated by PCR amplification and cloning, using a single 3Ј-end oligonucleotide primer (5Ј-dTGCATGGCTAGCGTCGACTGGCATGGGGT TGGCA) in tandem with each of the following 5Ј-end primers: pGEX-P 675-1620 (5Ј-dGGATCCCCGAAGCTTGGGAAAACT), pGEX-P 750-1620 (5Ј-dGAATT CGGCTTCCATTAAAAAGGGC), pGEX-P 820-1620 (5Ј-dCCAATGTGCTCG AAAG), pGEX-P 853-1620 (5Ј-dGCCAGGTGCACCTGC), and pGEX-P 890-1620 (5Ј-dGAGCAATGCCGCACT). The final construct in this series, pGEX-P 930-1620, was generated by digesting pGEX-P 890-1620 with BamHI and KpnI, followed by repair of the ends with Klenow fragment and subsequent religation.
Plasmid constructs designed to test frameshifting in eukaryotic cells were generated as follows. Both the V and P ORFs (extending only as far as the stop codon in the V reading frame) were amplified by PCR, using the primers 5Ј-dCTACGTGCTAGCATGGCAGAAGAACAGGCACGCC and 5Ј-dGGAT CCTTCTGGGATCTCGGGG, and subsequently cloned into pBL-PSV, which contains a simian virus 40 promoter and poly(A) signal flanking the pBluescript multiple cloning site (Stratagene). The chloramphenicol acetyltransferase (CAT) coding region was amplified by PCR, using the primers 5Ј-dGGATCCGAGA AAAAAATCACTGG and 5Ј-dGGATCCAAATTACGCCCCGCCC, before cloning into the BamHI site at the extreme 3Ј end of the P and V ORFs within, respectively, pBL-PSV-P and pBL-PSV-V. The resulting plasmids were termed P-CAT and V-CAT. Plasmid V-CAT contained a single ORF that extended unimpeded throughout the entire fused V and CAT coding regions, while the protein encoded by P-CAT was predicted to terminate at a stop codon within the proximal part of the CAT reading frame after translating the available portion of the P coding region. Plasmids V-CAT-⌬-F.S. and P-CAT-⌬-F.S. were identical to the parental plasmids V-CAT and P-CAT except that the last 30 nucleotides of the V or P reading frame (constituting the putative frameshift site) were removed by digestion with KpnI and BamHI, followed by repair of the ends with Klenow fragment and subsequent religation.
Additional plasmids used for studying the effect of sequences downstream of the frameshift site were generated by PCR amplification of the P ORF, using a common 5Ј primer (5Ј-dGGATCCGCAGAAGAGCAGGCACGC) along with each of the following 3Ј primers: pGEX-P full stem (5Ј-dTAGTTCTCCCCCTTC TTC), pGEX-P 1/2 stem (5Ј-dCTTCTTCATTATTCT), and pGEX-P no stem (5Ј-dT TATTCTGGGATCTCG).
Protein expression and analysis. Glutathione S-transferase (GST) fusion protein expression was induced on a small scale as described previously (43), with minor modifications. Overnight cultures were diluted 10-fold into LB-ampicillin medium and grown at 37ЊC for 1 h before induction with 0.1 mM isopropythiogalactopyranoside (IPTG; BRL) for 5 h. Total protein samples for Western blot (immunoblot) analysis were prepared by harvesting bacteria by centrifugation followed by lysis via heating at 100ЊC in protein lysis buffer prior to analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (SDS-PAGE) (10% polyacrylamide gel) by the method of Laemmli (27) . Proteins were electrophoretically blotted onto Immobilon-P membranes (Millipore) at 400 mA for 18 h in a Transfor model TE 50 (Hoefer Scientific Instruments) transfer apparatus. Western blotting was performed with the ProtoBlot alkaline phosphatase system as instructed by the manufacturer (Promega). Membranes were incubated with a rabbit antiserum directed against synthetic peptides corresponding to the 20 carboxy-terminal amino acids of the P protein (5) or the V protein (50), using a 1:10,000 dilution, followed by incubation with an alkaline phosphataseconjugated antibody directed against rabbit immunoglobulin G, using a 1:5,000 dilution. Color was developed with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate toluidinium (BCIP) until optimal signal/noise levels were achieved.
Protein purification and sequencing. Purification of truncated GST-R fusion protein was carried out with protein purified from 2,000 ml of bacterial culture induced with IPTG. Bacterial cells were harvested by centrifugation at 5,000 rpm (SS34 rotor in an RC-5B centrifuge) for 5 min before lysis by pulse sonication for 30 s three times (Vibra-Cell; Sonics and Materials Inc.). Triton X-100 was added to a final concentration of 1% (vol/vol), and the supernatant was clarified during centrifugation for 5 min at 5,000 rpm (SS34 rotor in an RC-5B centrifuge) before addition of 1 ml of a 50% slurry of glutathione-Sepharose beads (Pharmacia). Protein binding was allowed to proceed for 15 min at 4ЊC before the Sepharose beads were washed three times with 50 ml of phosphate-buffered saline and centrifuged at 500 rpm (SS34 rotor in an RC-5B centrifuge) for 1 min to collect the beads. After the final wash, the fusion proteins were eluted twice with 0.5 ml of 50 mM Tris (pH 8.0)-5 mM reduced glutathione (Pharmacia). Truncated GST-P protein (54 kDa) was separated from truncated GST-R (27 kDa) by ultrafiltration through a Centricon-30 (Amicon) spin column, after which the GST-R peptide was separated from glutathione and other low-molecular-weight compounds by using a Centricon-10 spin column. Approximately 10 g of the fusion protein was cleaved with 0.05 g of thrombin (ICN) for 2 h at 25ЊC in thrombin cleavage buffer (150 mM NaCl, 50 mM Tris [pH 7.5], 2.5 mM CaCl 2 ). Protein sequencing was carried out by the Eastern Quebec Peptide Sequencing Facility, Sherbrooke, Quebec, Canada, by applying the resulting mixture of GST and R peptides to an Applied Biosystems 473A protein sequencer equipped with an on-line Applied Biosystems 140A high-performance chromatography analyzer. ]cysteine (ICN Radiochemicals) for 1 h at 11 h postinfection in methionine-or cysteine-deficient DMEM (Gibco-BRL). Radiolabeled cell extracts were harvested in 500 l of either SDS solubilization buffer [1% 2-(N-cyclohexylamino) ethanesulfonic acid, 2% SDS, 1% dithiothreitol, 10% glycerol] for total protein analysis or in radioimmunoprecipitation assay (RIPA) buffer containing 1% bovine serum albumin (BSA) for immunoprecipitation as previously described (1) . Immunoprecipitation of in vivo-radiolabeled infected-cell proteins was performed with 200-l aliquots of cell extract that had been clarified during centrifugation at 14,000 rpm (Eppendorf centrifuge) for 5 min; 10 l of anti-V antiserum was added, and the mixture was incubated at 4ЊC for at least 3 h. Protein A-Sepharose beads (Pharmacia) were subsequently added, and the mixtures were incubated for a further 1 h. Bead-associated immune complexes were collected by brief centrifugation, and the beads were washed three times in RIPA buffer containing 1% BSA and then three times in RIPA buffer without BSA. Antigen-antibody complexes were disrupted by addition of 30 l of SDS solubilization buffer, incubated at 100ЊC for 5 min, and then centrifuged at 50,000 rpm (70Ti rotor in a Beckman L80 centrifuge) for 30 min at 4ЊC. Separation using the isoelectric point of the samples was performed by loading on an isoelectric focusing (IEF) gel, using the method of O'Farrell (34) . Briefly, IEF tube gels (internal diameter ϭ 3 mm) containing 55% urea, 4.24% acrylamide (30/1.8 [wt/wt] acrylamide/bisacrylamide ratio), and 0.5% ampholytes (Bio-Lyte 3/10; Bio-Rad) were prefocused at 200 V for 1 h prior to addition of samples. IEF of total and of immunoprecipitated protein was then carried out at 800 V for 18 h. Acrylamide tube gels were extruded from their glass cylinders and equilibrated in 125 mM Tris HCl (pH 6.8)-10% glycerol-2% SDS-5 mM dithiothreitol for 15 min. Molecular weight markers and equilibrated gels were then applied to the top of an SDS-8% polyacrylamide gel and separated on the basis of molecular weight by the method of Laemmli (27) . Protein gels were subsequently Coomassie stained, saturated with EnHance (NEN DuPont), and fluorographed at Ϫ80ЊC for 24 h. Quantitation of V and R proteins was carried out with a PhosphorImager (Molecular Dynamics) and ImageQuant software.
Cells and viruses. Vero cells were grown in
Transfections and CAT assays. Transfection studies were carried out with Vero cells grown in six-well plates to approximately 80% confluence. Five micrograms of plasmid was transfected by using LipofectACE (BRL) in serum-free DMEM during 5 h. At 24 h posttransfection, cells were harvested in 100 l of 0.25 M Tris-HCl (pH 8.0), lysed during three cycles of repetitive freezingthawing, and then clarified by centrifugation at 14,000 rpm (Eppendorf centrifuge) for 2 min. The resulting supernatants were assayed for CAT activity by using 0.025 mCi of [ 14 C]chloramphenicol for 4 h at 37ЊC and then analyzed by thin-layer chromatography (17) .
Protein quantitation of Western blots. To make accurate comparisons of the levels of R protein expressed under the control of different plasmid constructs, aliquots of the protein samples were first analyzed by SDS-PAGE and Coomassie blue staining. The total amounts of protein loaded on subsequent gels used for Western blotting were adjusted accordingly such that samples contained equivalent quantities of total protein. Band intensities were analyzed and quantitated with a Logitech ScanMan 256 scanner and Band Leader software, version 1.0. All quantitations mentioned were derived as the average of at least three separate experiments, Ϯ 1 standard deviation.
RESULTS
Bacterial expression of the MV P protein mRNA generates a protein which is immunologically cross-reactive with the MV V protein. To express the MV P and V proteins in Escherichia coli, we created constructs in which the entire coding regions corresponding to either the P or the V mRNA were fused in frame with the GST coding region within plasmid pGEX-2T. Western blot analysis of bacterially expressed proteins was carried out to analyze the polypeptide products expressed from these constructs. As can be seen in Fig. 1 , the pGEX-P construct directed the synthesis of an anti-P-reactive protein with electrophoretic mobility corresponding to that which would be predicted for the molecular mass (70 ϩ 26 ϭ 96 kDa) of a GST-P fusion protein, while pGEX-V was unable to direct the expression of any anti-P-reactive proteins. In a similar fashion, pGEX-V directed the expression of an anti-V-reactive protein corresponding in electrophoretic mobility to the predicted molecular mass (40 ϩ 26 kDa) of a GST-V fusion protein. Unexpectedly, however, pGEX-P also directed the expression of an anti-V-reactive protein band (which we designated GST-R) corresponding in electrophoretic mobility to the predicted molecular mass of a GST-V fusion protein. This finding suggested the possibility of a mechanism whereby ribosomes might be allowed to access the V ORF in the P mRNA transcripts, but not the reverse; i.e., ribosomes translating the V mRNA did not appear capable of obtaining access to the P ORF.
Localization of a coding shift site within the P mRNA sequence. It has previously been demonstrated that the editing of paramyxovirus P gene mRNA transcripts is a cotranscriptional event catalyzed by the virus-specific polymerase complex in the absence of host proteins and that it does not occur within mRNAs transcribed during expression from DNA vectors (20, 48) . It appeared unlikely, therefore, that such an editing event could be responsible for the coding shift event that we observed in E. coli. To elucidate the events taking place during bacterial expression, it was important to localize the exact site where a shift in coding frame was occurring and to examine this region in order to determine what sort of mechanism might be responsible for this event. A series of plasmid constructs containing successively greater amino-terminal deletions in the P-coding region was therefore produced (Fig. 2) . The reading frame for each of these constructs was confirmed by demonstrating their ability to produce a truncated GST-P fusion protein of the size predicted (data not shown). We subsequently performed Western blot analysis using antipeptide antisera of previously proven specificity against the P protein (1, 5) and the V protein (50) . These antisera reproducibly reacted against the P or the V protein from MV-infected cells but not against wild-type GST. Analysis using the anti-P antibody confirmed the specificity of these fusion proteins (Fig. 3) . Each of these plasmid constructs were then tested for its ability to direct synthesis of a protein product with immunologic reactivity with the anti-V antiserum (Fig. 3) . All of these constructs were seen to be capable of directing the synthesis of proteins which could be recognized by the anti-V antiserum. Each was of a size consistent with translation having termi- FIG. 1 . Western blot analysis of proteins expressed in E. coli under the direction of pGEX-2T (expressing only GST), pGEX-P (expressing the P protein ORF fused to that of GST), and pGEX-V (expressing the V protein ORF fused to that of GST). (A) GST, GST-P, and GST-V proteins were induced with IPTG, analyzed on an SDS-10% polyacrylamide gel, electroblotted onto polyvinylidene difluoride membranes, and immunostained with an anti-P antibody (␣P). The location of GST-P protein is indicated with an arrow. Sizes are indicated in kilodaltons. (B) A blot identical to that in panel A was prepared and immunostained with an anti-V antibody (␣V). The locations of GST-V and of the ribosomal frameshift product generated by the pGEX-P construct (GST-R) are indicated by arrows. nated at the V protein stop codon. This result indicated that the event causing a shift in coding frame was occurring within the region downstream of nucleotide 930 of the P mRNA yet still sufficiently upstream of the V stop codon at nucleotide 960 to allow continued immunoreactivity with antibody generated against the 20 carboxy-terminal amino acids of the V protein.
Determination of the frameshift site within the R protein, using direct protein sequence analysis. Demonstration that the MV R protein was indeed generated by ribosomal frameshifting required analysis of the amino acid sequence of the recoded protein product in the region where the V ORF was accessed. Plasmid construct pGEX-P 930-1620 was ideal for this purpose. The predicted amino acid sequence for both the 0 and Ϫ1 reading frames of GST-and MV-derived sequences within the vector DNA to a point beyond the stop codon for the V protein can be seen in Fig. 4A . Truncated GST-R and GST-P proteins expressed from pGEX-P 930-1620 were purified via their binding to glutathione-Sepharose beads. After elution from the beads with reduced glutathione, these two protein species were separated one from the other by passage through a Centricon-30 (Amicon) spin column, which retained the truncated 54-kDa GST-P protein while allowing passage of the truncated 27-kDa GST-R. The filtrate was then separated from glutathione and other small peptides by concentration on a Centricon-10 (Amicon) cartridge. Truncated R was cleaved from GST within the resulting concentrate by using thrombin (ICN) before being subjected to automated Edman sequencing on an Applied Biosystems 473A protein sequencer. Quantitation of the relevant phenylthiohydantoin-derived amino acids through the first 10 cycles of sequencing is shown in Fig. 4B . Subtraction of the amino acid signals which were predicted to derive from the structure of GST allowed generation of the amino acid sequence shown in Fig. 4A . The 0 reading frame was maintained through the first six residues shown, at which point ribosomes reading the CCG proline codon apparently slipped to the Ϫ1 CCC codon (also encoding proline). The remaining protein sequence was derived from the Ϫ1 ORF and terminated four amino acids downstream at the V stop codon.
Two-dimensional gel analysis of proteins reactive with an anti-V antiserum. During previous one-dimensional gel analysis of proteins immunoprecipitated from MV-infected cells, we were unable to detect the presence of a protein species corresponding to R protein in MV-infected cells (50) . The possibility remained, however, that multiple species of protein were comigrating as a 40-kDa band in such immunoprecipitation analysis. We proceeded to test this possibility by using two-dimensional gel electrophoresis. Radiolabeled proteins from MV-infected cells were immunoprecipitated with the anti-V antiserum (Fig. 5) before being denatured and applied to IEF gels for overnight separation on the basis of their isoelectric points. Acrylamide cylinders were then extruded from the glass tubes, and the focused proteins were subsequently separated on the basis of their molecular weights by SDS-PAGE (8% polyacrylamide gel). The single protein band seen after one-dimensional analysis was resolvable as two separate protein species in this two-dimensional gel system (Fig. 5 ). These two protein species correspond exactly in IEF position to their calculated pI values (4.31 for R, the left-hand species, and 4.59 for V, the right-hand species). By PhosphorImager analysis, the ratio of the relative intensity of V to R was 6.12:1 when 35 S]cysteine label was used. This 52% increase in relative labeling intensity when cysteine rather than methionine was used closely corresponded with the 46% increase that was anticipated from the predicted amino acid sequences of the R protein (containing 4 methionine and 6 cysteine residues) and the V protein (containing 5 methionine and 11 cysteine residues) and provides GST fusion protein constructs derived from the MV P/C/V cistron. Only the region relevant to the frameshift site is diagrammed. Cysteine residues are indicated by asterisks. The shaded region indicates the 20 carboxy-terminal amino acids against which the anti-V antiserum was raised.
FIG. 3.
Western blot analysis of the protein products expressed from aminoterminal deletion mutants of pGEX-P. (A) Full length GST-P protein and each of the amino-terminal deletion proteins were induced with IPTG, analyzed on an SDS-10% polyacrylamide gel, electroblotted onto polyvinylidene difluoride membranes, and immunostained with an anti-P antiserum (␣P). Each construct was observed to produce an anti-P-reactive GST fusion protein of the size predicted. (B) Protein samples were prepared and analyzed as for panel A except that immunostaining was carried out with the anti-V antiserum (␣V). Each of the deletion constructs was observed to generate a GST fusion protein that reacted with the V antiserum and was consistent in terms of observed molecular mass (indicated in kilodaltons) with translational termination having occurred at the V stop codon.
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on February 23, 2013 by PENN STATE UNIV http://jvi.asm.org/ additional strong evidence that the synthesis of the R protein is indeed directed by MV in infected cells. Quantitation of the radioactivity in these two proteins species resolved in this way allowed us to make a preliminary estimate that the in vivo molar ratio of V protein to R protein was approximately 5:1 (Fig. 5) . The actual molar ratios of V to R calculated from PhosphorImager data were 4.95:1 when [ 35 S]methionine label was used and 5.11:1 when [
35 S]cysteine label was used. Given that the in vivo molar ratio of P protein to V protein can be estimated to be 11:1 (estimated from data in reference 50), the frequency of frameshifting can be estimated to be approximately 1.8%. Since this estimate is made by using antisera which may have different affinities for the different proteins and we have not examined any effects resulting from different protein stabilities, it must be regarded as extremely rough and preliminary. Better estimation will likely require eukaryotic cell expression of the mRNA involved.
Confirmation that MV-specific sequences are capable of directing in vivo frameshifting by eukaryotic ribosomes. Protein sequence analysis indicated that the frameshift location was only five amino acids upstream of the carboxy terminus of the R protein. Detection of this protein in MV-infected cells has hitherto been hindered by the exact comigration of the V and R proteins on SDS-PAGE. Although two-dimensional gel analysis indicated that the 40-kDa MV-specific protein band could be resolved as two distinct protein species, we wished to more fully demonstrate that these two protein species resulted from ribosomal frameshifting in MV-infected eukaryotic cells. We were unable to generate functional antisera directed against peptides corresponding to regions of the MV P protein lying between the editing site and the frameshift site. Such antisera should have been able to identify both the 70-kDa P protein and the 40-kDa R protein but not the 40-kDa V protein. Lacking such antisera, we chose to use a reporter system to demonstrate whether the MV-specific sequences involved in prokaryotic ribosomal frameshifting were also capable of directing eukaryotic ribosomes to frameshift in a similar fasion in vivo in eukaryotic cells. We therefore constructed plasmid V-CAT (Fig. 6) , consisting of an simian virus 40 promoter and an ORF comprising the V coding region (excluding the V stop codon) fused in frame with the CAT coding region. Transfection of this plasmid into Vero cells generated CAT activity (Fig. 6) . The CAT activity of this fusion protein allowed us to test whether ribosomes could access the V protein ORF in a construct in which the CAT ORF was out of frame with the region upstream of it. We constructed plasmid P-CAT (Fig. 6 ) consisting of the P ORF up to, but not including, the V stop codon, fused out of frame with the CAT ORF. Ribosomal frameshifting from the P to the V ORF would generate the same protein product as was generated by the V-CAT construct. The P-CAT construct did indeed generate a frameshifted protein which expressed CAT activity in Vero cells (Fig. 6) . The frameshifting event, therefore, was not a phenomenon limited to bacterial cells. An additional set of constructs was generated from both the P-CAT and V- have been required to access the CAT reading frame, but in which the previously identified recoding site has been deleted, possessed no detectable CAT activity. Since deletion of the 30 nucleotides which included the frameshift site mapped from the E. coli protein product eliminated all evidence of frameshifting in the transfected cells, it is clear that the same frameshift site utilized in E. coli also operates in eukaryotic cells. Role of sequences downstream of the frameshift site. Although there are a number of different mechanisms by which ribosomes can decode an mRNA in a nonstandard fashion, most reported instances thus far involve tRNA slippage, usually by a single nucleotide to either the Ϫ1 or the ϩ1 reading frame. These events generally require two cis-acting components: (i) a so-called inherently slippery sequence and (ii) a downstream stimulator (reviewed in reference 2). Slippery sequences consist of a minimum of four or more identical nucleotides and often involve a more elaborate stretch of slipperiness in which a locus of two adjacent sets of codon-anticodon interactions can slip into the Ϫ1 frame while maintaining base pairing with third-position wobble. The consensus sequence for such heptameric regions is X XXY YYZ, where X, Y, and Z can be any of the four nucleotide bases.
In the MV P gene, the frameshift site matches only the minimum requirements with a run of four identical nucleotides. Such slippery sequences are, by themselves, seldom sufficient to allow the occurrence of high levels of frameshifting in the absence of downstream stimulator elements. Such downstream stimulator elements frequently consist of RNA secondary structure adjacent or near to the frameshift site. In vitro studies have demonstrated that such regions of downstream secondary structures can result in ribosomal pausing at or near the frameshift site, thereby increasing the probability that the ribosomes may slip at a given slippery sequence (44) . We wished to determine if such a stimulator element was present in the MV P protein mRNA. We used the Fold program of Jacobson et al. (24) to predict RNA secondary structure within the P mRNA in the region encompassing the frameshift site (Fig. 7A) . A series of four constructs we then generated to investigate whether the predicted secondary structures played a role in the frequency of frameshifting. pGEX-P contains all of the wild-type sequence 3Ј of the frameshift site (Fig. 7B) . pGEX-P full stem consists of the P ORF with deletion of sequences from the distal margin of the predicted stem-loop structure to the extreme 3Ј end of the mRNA. pGEX-P 1/2 stem contains a deletion which causes a more extensive disruption that extends to the midpoint of the predicted stem-loop structure. pGEX-P no stem contains the largest deletion, extending to the exact end of the V ORF, and is thus predicted to disrupt the entire putative stem-loop structure.
Our initial predictions, based on the retroviral model and the proposed secondary structure generated by the Fold program, were that the wild-type and full-stem constructs should demonstrate comparable levels of frameshifting, but that both the 1/2-stem and no-stem constructs should both generate similar and much reduced frequencies of frameshifting and of R protein. Expression of the R protein in each of these constructs was induced with IPTG under identical conditions. Bacteria were harvested, lysed in sample buffer, and analyzed by SDS-PAGE. Coomassie staining was used to standardize the total quantities of cellular proteins to be loaded on subsequent protein gels destined for Western blot analysis with the anti-V antisera. While the R protein expressed in the wild-type and full-stem constructs migrated normally, R protein expressed in the 1/2-stem construct comigrated with the truncated GST-P protein, resulting in a very diffuse band that was visually misleading (Fig. 7C ). In the no-stem construct, the truncated GST-P protein migrated slightly faster than the R protein, thereby displacing it upward. Optical scanning and computer analysis was used to accurately quantitate levels of expression of the R protein in all of these circumstances. The downstream sequences were indeed shown to be stimulatory. Deletion of all sequences 3Ј to the V stop codon resulted in a dramatic, 25-fold reduction in levels of R synthesis to 4% (Ϯ 2%) of wild-type levels (Fig. 7C) . Surprisingly, however, the 1/2-stem construct, which we would have predicted to be similar to the no-stem construct in level of stimulation, was indeed much more active in stimulation, with a level of frameshifting 55% (Ϯ 8%) of wild-type levels. This experiment confirmed that downstream MV-specific sequences do indeed stimulate the frequency of the frameshift event (by as much as 25-fold) but that the specific stem-loop structure predicted by our computer model does not fully explain the nature of the downstream stimulator region. Full characterization of this stimulator region will require further investigation.
DISCUSSION
In this report, we provide evidence that the MV P cistron is capable of encoding a previously unidentified protein, which we have designated R. Using an antiserum directed against a synthetic peptide corresponding to the exact carboxy terminus of the V protein, we detected this protein when a construct corresponding to the P protein mRNA was expressed as a GST fusion in E. coli. We have extended this observation by demonstrating that the converse is not true, i.e., that a corresponding V protein mRNA construct does not produce a protein recognized by an anti-P antibody. A number of amino-terminal deletions in the P fusion construct were constructed and tested for the ability to produce proteins that react with the carboxyterminal anti-V antiserum. All of these constructs generated proteins which were immunoreactive with carboxy-terminusspecific antisera against both the P and V proteins. This finding allowed us to map the recoding site to a region of only 24 nucleotides immediately upstream of the stop codon in the V protein reading frame. This smallest frameshifted protein was then purified, cleaved with thrombin, and subjected to aminoterminal protein sequencing. The resulting data indicated that the recoding event involves a ribosomal frameshift on a CCG proline codon to a Ϫ1 CCC proline codon. It was apparent that the protein product resulting from this frameshifting event contained only five amino acids derived from the V frame before terminating translation at the V protein stop codon. It thus derives its extreme carboxy terminus from the V ORF, with its remaining amino acids encoded in the P ORF. We have designated this new protein R.
Although the mechanistic process of Ϫ1 ribosomal frameshifting has already been demonstrated to be conserved between prokaryotes and eukaryotes, we desired stronger evidence that this frameshifting event was likely to be occurring during the normal course of MV infection. The previous failure to detect this protein during P protein expression experiments is likely due to the facts that (i) the R protein comigrates exactly with the V protein during one-dimensional protein gel analysis, making it impossible to distinguish from the V protein, and (ii) anti-V antisera would detect R only if they exhibited immunoreactivity against the five very last carboxyterminal amino acids, which are the only ones common to both V and R. The MV V and R proteins have a number of similarities. The V protein has a 231-amino-acid amino-terminal domain in common with the P protein. This is fused to a unique carboxyterminal domain of 68 amino acids. In contrast, the R protein has a 294-amino-acid amino-terminal domain in common with the P protein; this is fused to a 5-amino-acid carboxy-terminal domain derived from the V ORF. Thus, the V and R proteins are of identical length, 299 amino acids, of which 236 are identical (231 identical residues at the amino terminus, followed by 63 nonidentical residues, and terminating with 5 carboxy-terminal identical residues). The predicted pIs for these highly similar proteins are also similar (4.31 for R and 4.59 for V). Despite this, we have successfully demonstrated that the 40-kDa protein band obtained by specific immunoprecipitation of MV-infected cell extracts with our anti-V antiserum can, in fact, be resolved as two distinct protein species by two-dimensional gel analysis. These protein species exhibited nearly exactly the relative labeling efficiencies anticipated from their predicted sequences when [ 35 S]cysteine rather than [ 35 S]methionine was used for radiolabeling. From the quantity of R and V protein synthesized during the course of a 1-h radiolabeling procedure, we estimate that ribosomal frameshifting on the P mRNA occurred with an approximate relative frequency of 1.8%. This estimate is consistent with estimates from other viral instances of ribosomal frameshifting, which vary from 0.7 to 30% (reviewed in reference 38). This estimate must be considered preliminary for two reasons. The anti-V antiserum used in the immunoprecipitation was generated against a synthetic peptide corresponding to the 20 carboxyterminal amino acids of V. The R protein shares only five of these amino acids, which raises the possibility that this polyclonal antiserum has different affinities for the two proteins. Moreover, the estimate of frameshift frequency is based on protein accumulation, and while we have previously shown P to be a highly stable protein (1), we have not yet determined the half-life of the R protein. If our estimate is inaccurate, then we may if anything be underestimating the actual frequency of the MV frameshifting event.
To provide additional evidence that the second species of 40-kDa protein (with the more acidic pI) did indeed result from a ribosomal frameshifting event, we used a transfectionbased CAT gene reporter system to demonstrate that in vivo eukaryotic cell ribosomal frameshifting was in fact occurring on the MV P mRNA. Ribosomal frameshifting was required in our system to generate a P-CAT fusion protein that exhibited demonstrable CAT activity. Not only did we observe such activity with the P-CAT construct, deletion of a 30-nucleotide region encompassing the frameshift site in this construct resulted in a complete obliteration of CAT activity. The ribosomal frameshift site defined in E. coli does indeed operate in eukaryotic cells, and thus ribosomal frameshifting is the likeliest explanation for the presence of the second 40-kDa protein species which is reactive with the anti-V antiserum.
We have also examined the role of sequences downstream of the frameshift site. Elimination of all sequences 3Ј to the stop codon, which is 15 nucleotides downstream of the frameshift site, resulted in an at least 25-fold decrease in the relative frequency of frameshifting. This observation is consistent with evidence derived from study of the retroviral consensus frameshift site. This consists of an inherently slippery heptanucleotide sequence element followed by downstream stem-loop structures. These latter often form RNA pseudoknots that increase the frequency of frameshifting and essentially act as stimulator elements. Although the Fold program of Jacobson et al. (24) predicts a limited stem-loop structure immediately downstream of the V protein stop codon, we found that deletions that were predicted to disrupt this putative stem-loop failed to decrease the frameshift frequency as greatly as did complete removal of the region (2-fold versus 25-fold) . This result appears to indicate that either the frameshift site contains some form of stimulatory element distinct from secondary structure requirements analogous to the traditional retroviral frameshift site or else that the Fold program failed, in this case, to accurately predict the secondary structure in this region. Further experiments are required to more fully define the downstream stimulatory element or elements.
Ribosomal frameshifting was initially discovered in the GagPol junctions of Rous sarcoma virus (23), an observation that was then extended to the yeast retrotransposon Ty (32) and other retrovirus and retrovirus-like elements. In addition, the catalog of viruses which take advantage of such a recoding strategy has been greatly extended to include a coronavirus (infectious bronchitis virus) (9) , an astrovirus (29), a totivirus (giardiavirus) (49) , and several plant dianthoviruses, including red clover necrotic mosaic virus (51) and luteoviruses such as barley yellow dwarf virus (8) . Interestingly, this collection of disparate viruses all use ribosomal frameshifting to regulate the synthesis of their RNA-dependent RNA polymerases. At the present time, MV is the only negative-stranded RNA virus that has been demonstrated to employ this form of gene expression strategy. Both the V and the R proteins contain the P protein amino-terminal domain that has been shown to interact with the polymerase protein (19, 21) . It is thus not impossible that the protein product of this virus frameshifting event is in some way involved in polymerase function. The evolution of two separate mechanisms (editing and ribosomal frameshifting) as well as the extreme conservation of the cysteine-rich domain unique to the V protein all suggest a criticality of function for the P cistron-related gene products. Given that the state of our understanding of the protein functions of previously discovered members of this family of proteins is currently nearly entirely inadequate, it comes as no surprise that the function or functions of the R protein thus far also remain mysterious.
